Live now · Published Benchmarks
PoS Benchmarks (BIO/QLS 2021)
Stage-transition probabilities by indication + evidence-based multipliers. Version-stamped, JSON-callable.
PhaseFolio Network
Network Benchmarks
Anonymized, audit-grade biotech investment benchmarks — published quarterly starting Q4 2026.
Median trial costs by indication × modality. Phase-by-phase duration distributions. Sponsor pattern signals. All anonymized, all citable, all free at the headline level.
What's Coming Q4 2026
- · Median Phase II trial cost by indication (top 12 indications)
- · Phase-to-approval timeline distributions
- · PoS multiplier effective values (network-calibrated)
- · Annual data dump in CSV + JSON, suitable for academic citation